Over 13 years international banking experience in corporate finance for listed vehicles in Hong Kong and PRC, together with asset management experience in leading aircraft leasing institution including structured finance, equity funding and debt funding in Asia. Daisy is responsible for fundraising activities, business development and investors relations, investment performance monitoring, closing of investment transactions and overall fund administration and operations on a daily basis.
Over 25 years’ experience as an investment professional with leading asset management groups in the United States, Asia and Australiaincluding, amongst other roles, Head of Global Fixed Income Product (Asia Pacific) at JPMorgan Asset Management. Dr. Fisher had investments responsibility for the firm’s mandates of totalling USD20 billion assets from Sovereign Wealth Funds, Central Banks and some largest institutions on reserves management and asset allocation. Dr. Fisher is responsible for sourcing investments, advising on macro-economic trends, regulatory compliance and fund administration.
A successful entrepreneur who has established solid relationships with many listed companies and securities firms in Hong Kong. Kelvin and his execution team in Hong Kong, assist in sourcing potential investments and undertake fund raising in both Hong Kong and PRC. In addition, he plays a critical role in incubating portfolio companies to minimize their failure rate and enhance their valuation before the Fund’s exit.
Over 15 years of experience in the research and development space of advanced technologies. Felix successfully developed an unmanned navigation system in a German research institute with OPEL as well as developing robotics for outer space exploration with European Aerospace. Felix is responsible for advising us on AI, TMT & Fintech projects for the Fund, and will also handle deal sourcing, due diligence and M&A transactions in both private equity and in the secondary market.
A Ph.D. at the University of Hong Kong, Joe and his team have developed over 20 diagnostic instruments and kits, established over 50 clinical diagnostic service tests and own over 20 patents in the biotechnology sector. Joe’s medical technology experience brings valuable expertise in biotechnology investments to the Fund. Joe is also a serial entrepreneur specialising in bringing technologies and products to Chinese market.